Patents by Inventor Da Seul Im

Da Seul Im has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • NOVEL QUINAZOLINE DERIVATIVE HAVING FLT3 INHIBITORY ACTIVITY, AND USE THEREOF
    Publication number: 20230357164
    Abstract: The present invention relates to a novel quinazoline derivative having fms-like tyrosine kinase 3 (FLT3) inhibitory activity, and a use thereof. A novel quinazoline derivative or a pharmaceutically acceptable salt thereof, according to the present invention, exhibits excellent inhibitory activity against FLT3, and thus targeted treatment through more fundamental approaches is expected in the prevention or treatment of acute myeloid leukemia (AML).
    Type: Application
    Filed: September 24, 2021
    Publication date: November 9, 2023
    Inventors: Jung-Mi Hah, Da Seul Im
  • Novel Imidazole Derivative Expressing FLT3 Inhibitory Activity, and Use Thereof
    Publication number: 20220315573
    Abstract: The present invention relates to a novel benzimidazole derivative having fms-like tyrosine kinase 3 (FLT3) inhibitory activity, and a use thereof. A novel benzimidazole derivative or a pharmaceutically acceptable salt thereof, according to the present invention, exhibits excellent inhibitory activity against FLT3, and thus targeted treatment through more fundamental approaches is expected in the prevention or treatment of acute myeloid leukemia (AML).
    Type: Application
    Filed: August 12, 2020
    Publication date: October 6, 2022
    Applicant: Industry-University Cooperation Foundation Hangyang University Erica Campus
    Inventors: Jung Mi Hah, Da Seul Im